Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
I. E. Elkholi, A. Robert, C. Malouf…·J.-F. Cote
This study identifies Pik3c3 as a vulnerability in dormancy-prone breast cancer cells, showing its inhibition reduces metastasis in preclinical models.
D. Sun, D. Filipescu, D. Hasson…·J. A. Aguirre-Ghiso
This study shows macroH2A2 promotes dormancy in disseminated cancer cells, preventing metastasis without requiring known dormancy factors.
D. K. Singh, E. Farias, S. Carcamo…·J. A. Aguirre-Ghiso
The paper shows that AZA+atRA treatment induces dormancy in DCCs by restoring TGFβ-SMAD4 signaling, suppressing lung metastasis.
V. Calvo, W. Zheng, K. A. Staschke…·J. A. Aguirre-Ghiso
This study shows that PERK inhibition reduces metastasis by targeting dormant cancer cells through UPR-dependent mechanisms.
B. D. Khalil, R. Sanchez, T. Rahman…·J. A. Aguirre-Ghiso
This study identifies a novel NR2F1 agonist, C26, that suppresses metastasis by inducing cancer cell dormancy through NR2F1 activation in HNSCC.
A. R. Nobre, E. Risson, D. K. Singh…·J. A. Aguirre-Ghiso
This study shows NG2+/Nestin+ mesenchymal stem cells in the bone marrow use TGFβ2 to induce dormancy in breast cancer disseminated tumor cells.